Our team relies on its many years of experience and past successes, to prepare and execute numerous technology transfers for the manufacture of hyaluronic acid products (cross-linked or non-cross-linked HA), in Europe but also outside Europe, particularly in China and the Middle East. These operations have led us in particular to improve the pre-existing technologies at our customers, scale up and provide them with more modern technologies.
Company
Technology transfer
Explore our environment
-
Syrhatech completes a financinground of CHF 4.5 million
Plan-les-Ouates, Geneva, April 2025 – Syrhatech, a French-Swiss CDMO innovating in thedevelopment and manufacture of…
-
Welcoming the New Year with Innovation and Leadership at SyrhaTech
As we step into the New Year, SyrhaTech is excited to announce a significant addition…
-
Financing the future: SyrhaTech aims for new heights
No company is more future-oriented at the moment than SyrhaTech: a Biotech medical device company…
-
SyrhaTech supports organization of ISHAS’s awards
For the past four months, SyrhaTech has been in partnership with the learned society ISHAS…
-
SyrhaTech, an aesthetic medical device company, between France and Switzerland
The SyrhaTech team is made up of people from Europe’s four corners. Everyone is very…
-
SyrhaTech joins CDMO France
SyrhaTech is proud to announce that we have joined the “CDMO France” association. CDMO France…
-
They Trust SyrHA : The Excellence of a CDMO
At SyrHA, we believe that the cornerstone of our success is the unwavering trust that…
-
Announcing strategic partnership : SyrHA the CDMO and ISHAS organization
We are pleased to inform you that SyrHA has joined the International Society for Hyaluronic…
-
CDMO: Evolution of their role
Innovative biopharmaceutical companies are increasingly engaging in strategic partnerships with CDMOs, whereas in the past,…
-
Join us at IMCAS Paris!
We’re delighted to announce that our team will be taking part in the IMCAS 2024…
